Medicare Part D coverage · ritlecitinib · RxCUI 2641607
ritlecitinib 50 MG Oral Capsule [Litfulo]
Per the CMS 2026 Part D formulary file, ritlecitinib 50 MG Oral Capsule [Litfulo] is covered by 276 Medicare Part D plans (5.5% of enrollable products), averaging Tier 3.8, with prior authorization required on 97.9% of covering formularies.
- 5.5%
- Plan coverage
- 276
- Plans covering
- T3.8
- Avg tier
- 97.9%
- Prior auth required
What the CMS Formulary Data Shows for ritlecitinib 50 MG Oral Capsule [Litfulo]
Per the CMS 2026 Part D formulary file, ritlecitinib 50 MG Oral Capsule [Litfulo] (RxNorm concept RXCUI 2641607, generic name ritlecitinib) appears on 48 distinct formulary files spanning 276 Medicare Part D plan offerings - 5.5% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 3.8.
Real-world access to ritlecitinib 50 MG Oral Capsule [Litfulo] depends on utilization management as much as tier placement: 97.9% of covering formularies require prior authorization. 0% require step therapy. 87.5% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 26 Part D beneficiaries filled ritlecitinib 50 MG Oral Capsule [Litfulo] in 2023, with total plan-and-beneficiary spending of $223,742 and an average per-beneficiary annual cost of $8,605.48. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry ritlecitinib 50 MG Oral Capsule [Litfulo] today.
Coverage Details
- Formularies covering
- 48
- Plans covering
- 276
- Coverage rate
- 5.5%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 97.9% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 87.5% of formularies
2023 Medicare Spending
- Beneficiaries
- 26
- Total spending
- $223,742
- Avg per beneficiary
- $8,605.48
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering ritlecitinib 50 MG Oral Capsule [Litfulo]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| PruittHealth Premier D-SNP (HMO D-SNP) | Pruitthealth Premier, Inc. | T1 | Yes | $0 | GA |
| Simpra Advantage Dual Care (PPO D-SNP) | Simpra Advantage, Inc. | T1 | Yes | $0 | AL |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | Yes | $0 | CA |
| Senior Care (HMO I-SNP) | Align Senior Care Florida, Inc. | T1 | Yes | $4.80 | FL |
| ProCare Advantage (HMO-POS I-SNP) | Procare Advantage, LLC | T1 | Yes | $4.80 | TX |
| ProCare Advantage - Kidney Care (HMO-POS C-SNP) | Procare Advantage, LLC | T1 | Yes | $4.80 | TX |
| American Health Advantage of Florida (HMO I-SNP) | American Health Plan OF FL, Inc. | T1 | Yes | $4.80 | FL |
| SECUR Advantage (HMO I-SNP) | Secur Inc | T1 | Yes | $4.80 | FL |
| SECUR Enhanced (HMO I-SNP) | Secur Inc | T1 | Yes | $4.80 | FL |
| Senior Care (HMO I-SNP) | Align Senior Care MI, LLC | T1 | Yes | $8.80 | MI |
| AgeRight Advantage Health Plan (HMO I-SNP) | Marquis Advantage, Inc. | T1 | Yes | $10.50 | OR, WA |
| Senior Care (HMO I-SNP) | Align Senior Care California Inc. | T1 | Yes | $12.00 | CA |
| Liberty Medicare Dual Plan (HMO D-SNP) | Liberty Advantage, LLC | T1 | Yes | $14.70 | NC |
| KeyCare Advantage (HMO I-SNP) | Isnp Ventures, LLC | T1 | Yes | $23.20 | MD |
| American Health Advantage of Mississippi (HMO I-SNP) | American Health Plan OF MS, Inc. | T1 | Yes | $23.80 | MS |
| Senior Care (HMO I-SNP) | Lifeworks Advantage, LLC | T1 | Yes | $24.60 | VA |
| PruittHealth Premier (HMO I-SNP) | Pruitthealth Premier, Inc. | T1 | Yes | $25.40 | GA |
| Georgia Health Advantage (HMO I-SNP) | Georgia Assurance, Inc. | T1 | Yes | $25.40 | GA |
Show the next 30 plans
| Georgia Health Advantage Choice (HMO I-SNP) | Georgia Assurance, Inc. | T1 | Yes | $25.40 | GA |
| American Health Advantage of Tennessee (HMO I-SNP) | American Health Plan, Inc. | T1 | Yes | $27.70 | TN |
| Simpra Advantage Nursing Home Plan (PPO I-SNP) | Simpra Advantage, Inc. | T1 | Yes | $27.70 | AL |
| American Health Advantage of Oklahoma (HMO I-SNP) | Oklahoma Superior Select, Inc. | T1 | Yes | $28.20 | OK |
| NHC Advantage (HMO I-SNP) | NHC Advantage, LLC | T1 | Yes | $31.00 | MO, NC, SC, TN |
| Perennial Advantage Strive (HMO I-SNP) | Perennial Advantage OF Ohio, Inc. | T1 | Yes | $31.40 | OH |
| Perennial Advantage Strive (HMO I-SNP) | Perennial Advantage OF Colorado, Inc. | T1 | Yes | $32.70 | PA |
| American Health Advantage of Pennsylvania (HMO I-SNP) | American Health Plan OF Pennsylvania Inc | T1 | Yes | $32.70 | PA |
| Lagniappe Advantage (PPO I-SNP) | Lagniappe Advantage Insurance Company | T1 | Yes | $32.90 | LA |
| American Health Advantage of Louisiana (HMO I-SNP) | Dignity Care Corporation | T1 | Yes | $32.90 | LA |
| Perennial Advantage Strive (HMO I-SNP) | Perennial Advantage OF Colorado, Inc. | T1 | Yes | $35.20 | CO |
| PruittHealth Premier (HMO I-SNP) | Pruitthealth Premier North Carolina, LLC | T1 | Yes | $35.70 | SC |
| PruittHealth Premier (HMO I-SNP) | Pruitthealth Premier North Carolina, LLC | T1 | Yes | $36.20 | NC |
| Liberty Medicare Advantage Nursing Home Plan (HMO I-SNP) | Liberty Advantage, LLC | T1 | Yes | $36.20 | NC |
| American Health Advantage of Utah (HMO I-SNP) | American Health Plan OF UT, Inc. | T1 | Yes | $37.60 | UT |
| American Health Advantage of Idaho (HMO I-SNP) | American Health Plan OF UT, Inc. | T1 | Yes | $37.60 | ID |
| American Health Advantage of Indiana (HMO I-SNP) | American Health Plan OF Indiana Inc | T1 | Yes | $38.40 | IN |
| Iowa Health Advantage (HMO I-SNP) | American Health Plan OF Iowa Inc | T1 | Yes | $41.50 | IA |
| Iowa Health Advantage Choice (HMO I-SNP) | American Health Plan OF Iowa Inc | T1 | Yes | $41.50 | IA |
| American Health Advantage of Missouri (HMO I-SNP) | American Health Plan OF Missouri, Inc. | T1 | Yes | $43.00 | MO |
| American Health Advantage of Missouri Choice (HMO I-SNP) | American Health Plan OF Missouri, Inc. | T1 | Yes | $43.00 | MO |
| Kansas Health Advantage (HMO I-SNP) | Kansas Superior Select, Inc. | T1 | Yes | $55.20 | KS |
| Kansas Health Advantage Choice (HMO I-SNP) | Kansas Superior Select, Inc. | T1 | Yes | $55.20 | KS |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T2 | Yes | $0 | CA |
| Community Blue Medicare HMO Signature (HMO) | Highmark Western and Northeastern New York Inc. | T5 | Yes | $0 | NY |
| Community Blue Medicare HMO Merit (HMO) | Highmark Western and Northeastern New York Inc. | T5 | Yes | $0 | NY |
| Community Blue Medicare PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Community Blue Medicare Plus PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is ritlecitinib 50 MG Oral Capsule [Litfulo] covered by Medicare Part D?
Yes, ritlecitinib 50 MG Oral Capsule [Litfulo] is covered by 276 Medicare Part D plans (5.5% of all Part D formularies).
What tier is ritlecitinib 50 MG Oral Capsule [Litfulo] on Medicare Part D plans?
ritlecitinib 50 MG Oral Capsule [Litfulo] averages Tier 3.8 across Part D plans, ranging from Tier 1 to Tier 5.
Does ritlecitinib 50 MG Oral Capsule [Litfulo] require prior authorization?
97.9% of Part D formularies require prior authorization for ritlecitinib 50 MG Oral Capsule [Litfulo]. Step therapy: 0%. Quantity limits: 87.5%.
How much does Medicare spend on ritlecitinib 50 MG Oral Capsule [Litfulo]?
In 2023, total Medicare Part D spending on ritlecitinib 50 MG Oral Capsule [Litfulo] was $223,742, covering 26 beneficiaries. The average spend per beneficiary was $8,605.48.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- 0.5 ML ustekinumab-kfce 90 MG/ML Injection [Yesintek] 97.9% PA
- 0.5 ML ustekinumab-kfce 90 MG/ML Prefilled Syringe [Yesintek] 97.9% PA
- 1.7 ML denosumab 70 MG/ML Injection [Xgeva] 97.9% PA
- levodopa 42 MG Inhalation Powder [Inbrija] 97.9% PA
- fenfluramine 2.2 MG/ML Oral Solution [Fintepla] 97.9% PA
- 0.2 ML adalimumab-ryvk 100 MG/ML Prefilled Syringe [Simlandi] 97.9% PA